We are live on ! Find out more
KURA icon

Kura Oncology
KURA

98 hedge funds and large institutions have $442M invested in Kura Oncology in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 8

50% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 22

48% more capital invested

Capital invested by funds: $299M → $442M (+$143M)

29% more funds holding

Funds holding: 76 → 98 (+22)

6.03% more ownership

Funds ownership: 64.64% → 70.68% (+6%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

65% less call options, than puts

Call options by funds: $17K | Put options by funds: $49K

Holders
98
Holders Change
+22
Holders Change %
+28.95%
% of All Funds
2.25%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
31
Increased
33
Reduced
22
Closed
8
Calls
$17K
Puts
$49K
Net Calls
-$32K
Net Calls Change
-$35K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.8M
2
State Street
State Street
Massachusetts
+$9.55M
3
SFM
Sphera Funds Management
Israel
+$6.42M
4
SCM
Sio Capital Management
New York
+$5.17M
5
Millennium Management
Millennium Management
New York
+$4.25M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$8.03M
2
Morgan Stanley
Morgan Stanley
New York
-$3.47M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.65M
4
CS
Candriam SCA
Luxembourg
-$2.53M
5
NC
Nexthera Capital
New York
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCIM
51
Meadow Creek Investment Management
Georgia
$601K +$624K +32,060 New
UBS Group
52
UBS Group
Switzerland
$575K +$354K +18,171 +145%
B
53
Bailard
California
$563K -$74.1K -3,805 -11%
JMPWA
54
JP Morgan Private Wealth Advisors
California
$553K – – –
AQR Capital Management
55
AQR Capital Management
Connecticut
$533K +$553K +28,405 New
PPCM
56
Pillar Pacific Capital Management
California
$527K -$34.1K -1,750 -6%
Goldman Sachs
57
Goldman Sachs
New York
$527K -$21.8K -1,119 -4%
Citigroup
58
Citigroup
New York
$499K +$331K +17,029 +178%
RSCM
59
Rock Springs Capital Management
Maryland
$497K +$516K +26,500 New
EP
60
Elkfork Partners
Oregon
$472K +$490K +25,190 New
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$416K – – –
AIM
62
Assured Investment Management
New York
$350K +$364K +18,689 New
TAM
63
Tyers Asset Management
Texas
$344K +$357K +18,320 New
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$339K +$81K +4,160 +30%
BCM
65
Bridgeway Capital Management
Texas
$338K -$958K -49,200 -73%
Squarepoint
66
Squarepoint
New York
$331K +$121K +6,199 +54%
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$315K +$17.3K +887 +6%
ProShare Advisors
68
ProShare Advisors
Maryland
$314K -$49.6K -2,550 -13%
AIG
69
American International Group
New York
$258K +$3.5K +180 +1%
Federated Hermes
70
Federated Hermes
Pennsylvania
$251K +$5.24K +269 +2%
Wellington Management Group
71
Wellington Management Group
Massachusetts
$251K +$260K +13,355 New
ECM
72
Element Capital Management
New York
$238K +$247K +12,693 New
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$226K +$239K +12,300 New
AllianceBernstein
74
AllianceBernstein
Tennessee
$214K +$222K +11,400 New
PIM
75
Partner Investment Management
California
$210K -$144K -7,372 -40%
1 2
3
4 5

KURA Hedge Fund Activity: Q1 2018 in Review

98 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2018, worth a combined $442M — up 48% from $299M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new KURA positions and 8 closed out — a net gain of 23 holders — while 33 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $45.8M. The largest seller was PFM Health Sciences, cutting an estimated $8.03M.

  • 98 institutional investors held Kura Oncology (KURA) as of Q1 2018, up from 76 in Q4 2017.
  • Funds reported $442M of Kura Oncology stock for Q1 2018, up 48% quarter-over-quarter.
  • 31 funds opened new Kura Oncology positions in Q1 2018 and 8 closed out, a net change of +23 holders.
  • The largest Kura Oncology buyer in Q1 2018 was Fidelity Investments, an estimated $45.8M added.
  • The largest Kura Oncology seller in Q1 2018 was PFM Health Sciences, an estimated $8.03M sold.

Based on aggregated 13F filings for Q1 2018.